How One Clinical Pharmacist Can Have A Profound Impact On Hospital Readmissions

December 12, 2024Bedside Prescription Delivery, Meds To Beds, Outpatient Tracking, Readmissions Reduction

There are so many reasons Brandi Henneman has had such a positive impact on participation rates for ProxsysRx’s Readmission Reduction program at South Carolina’s Conway Medical Center. Chief among them, her first-rate professionalism, and her genuinely caring disposition — which immediately tells patients she has their best interests at heart. It’s a sense of comfort … Read More

A Program For Achieving Readmission Reduction. One Patient At A Time.

November 5, 2024Bedside Prescription Delivery, Meds To Beds, Readmissions Reduction, Value-Based Care

As noted in a 2018 study conducted by the National Institutes Of Health (NIH), one of the cornerstones of the 2010 Patient Protection and Affordable Care Act (ACA) is the Hospital Quality Initiative for enhancing patient safety, reducing hospital readmissions, improving quality, and minimizing healthcare costs. The cost of patient readmissions to hospitals According to … Read More

Overcome 340B ESP & Other Manufacturer Restrictions With Software And Human Insight

August 28, 2024340B, 340B ESP, Bedside Prescription Delivery, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, Overview, Specialty Drugs, Specialty Pharmacy, TPA / TPAs

POST OUTLINE PHASE ONE: Organizing 340B data, coordinating teams Connecting and educating 340B system providers Requalifying all eligible, but unreimbursed, 340B scripts Retrieving 340B eligible-script data Establishing communication lines between internal and external 340B teams Why specialized software is essential for successful 340B programs The central problem with most 340B programs’ data Why 340B software … Read More

Using 340B To Optimize Patient Care And ROI Throughout Your Health System

August 7, 2024340B, 340B ESP, Compliance, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, Patient Eligibility, Prescription Discounts, Readmissions, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy, TPA / TPAs

Far too many 340B hospitals overlook pharmacy’s overall potential in their health systems’ revenue cycles. Below is a graphic overview of ProxsysRx’s integrated approach to optimizing a health system’s pharmacy services, savings and revenue. In 340B support alone, we’ve generated over $500 million for the hospitals we serve — revenue those systems have used to … Read More

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

April 4, 2024340B, 340B ESP, Bedside Prescription Delivery, Compliance, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, Prescription Discounts, Requirements, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy

Why a Specialty Pharmacy? (Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. According to a report by The American Hospital Association, the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase … Read More

For TMH Pharmacist-In-Charge Mariana Elia, It’s All About The Relationship.

March 20, 2024Meds To Beds, Pharmacy Careers, ProxsysRx Profile, Retail / Outpatient Pharmacy

If you’re a first-time patient of ProxsysRx’s pharmacy at Tallahassee Memorial Healthcare, and you want to get Mariana Elia talking, really talking, it helps to know key trigger words. Key words and phrases like “Hello,” “How are you?” and “Tell me about yourself.” All highly effective for starting a lively conversation, to be sure. But … Read More

The Best 340B Program Is More Than Just A 340B Program. Much More.

March 12, 2024340B, Bedside Prescription Delivery, Contract Pharmacy, Drug Manufacturer Restrictions, Meds To Beds, Specialty Drugs, Specialty Pharmacy, TPA / TPAs

Congress established the 340B program in 1992 to help non-profit hospitals fill-in the significant revenue gaps inherent to their business models. What the bill’s supporters did not foresee, and what very few eligible health systems realize — even today — is that 340B can function as the central hub of a multi-point program. One that … Read More

Using 340B To Optimize Patient Care And ROI Throughout Your Health System

March 7, 2024340B, 340B ESP, Bedside Prescription Delivery, Contract Pharmacy, Meds To Beds, Patient Eligibility, Prescription Discounts, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy, TPA / TPAs

Below is a graphic overview of ProxsysRx’s integrated approach to optimizing a health system’s pharmacy services, savings and revenue. In 340B support alone, we’ve generated over $500 million for the hospitals we serve — revenue those systems have used to positively impact the quality and scope of patient care they offer, in countless ways. Why … Read More